TLR9 and asthma: This was evaluated in in vivo models where TLR9 activation was found to be associated with a reduction in antigen-induced respiratory allergic responses [65, 66], suggesting that TLR9 ligands could be used as prophylactic and therapeutic agents in asthma [67].